Sanofi

We chase the miracles of science so you can chase your dreams.

Learn more

Our Latest Articles

3D molecular model of a NANOBODY® molecule showing purple and gray spheres connected by bonds against a gradient background

Our Science

January 26, 2026

Two’s Company. Three’s a Crowd. Five Nanobody® Subunits? That Could Be a New Medicine.

Two women in black wetsuits standing on a beach with a surfboard, ready for surfing

The Power of Chasing A Dream

Every day, we chase the miracles of science to improve people’s lives. We apply our deep understanding of the immune system to develop breakthrough innovations in medicines and vaccines so you can focus on what matters most, chasing your dreams. If you’re chasing your dreams, remember... you’re not alone. We’re right beside you. 

 

People Stories

We’re proud to spotlight those who inspire us to keep going further in the work we do.

A woman wearing a black wetsuit holds a surfboard under blue skies and sunshine while looking out to the horizon with a hopeful and determined expression.​

Céline, living with secondary progressive multiple sclerosis

France

We are an R&D driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth

About Us

Who We Are

We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.

Our Pipeline

5

Therapeutic areas

80

Compounds in clinical development

28

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases


February 16, 2026
Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season

February 12, 2026
Press Release: Belén Garijo to become Chief Executive Officer of Sanofi

February 10, 2026
Press Release: Sanofi completes the acquisition of Dynavax

February 9, 2026
Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia